Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 20.6B | 22.7B | 18.7B | 17.5B |
Cost of revenue | 11.5B | 12.8B | 10.5B | 9.9B |
Gross profit | 9.1B | 9.9B | 8.2B | 7.6B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 6.0B | 6.8B | 5.6B | 5.0B |
Operating income | 604.5M | 709.6M | 400.4M | 360.6M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 298.5M | 319.3M | 242.3M | 213.1M |
Other income expense | — | — | — | — |
Pretax income | 395.5M | 445.6M | 212.6M | 220.8M |
Tax provision | 205M | 175.9M | 78.2M | 78.4M |
Net income | 190.5M | 264.1M | 129.7M | 136.4M |
Basic EPS | — | 0.1 | 0.0 | 0.0 |
Diluted EPS | — | 0.1 | 0.0 | 0.0 |
Basic average shares | — | 2.9B | 2.5B | 3.2B |
Diluted average shares | — | 2.9B | 2.5B | 3.2B |
EBITDA | 1.4B | 1.5B | 1.1B | 1.0B |
Net income from continuing op. | — | — | — | — |
Minority interests | 12.4M | -2.9M | -29.3M | -40M |
Preferred stock dividends | 0 | 0 | 0 | 0 |